Management of pregnant women with antiphospholipid antibodies
A Ruffatti, M Favaro, A Calligaro… - Expert review of …, 2019 - Taylor & Francis
… Hypothetically the pathogenesis of APS pregnancy morbidity depends on the thrombogenic
effect of antiphospholipid antibodies (aPL) that may cause a slow, progressive thrombosis …
effect of antiphospholipid antibodies (aPL) that may cause a slow, progressive thrombosis …
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
JS Knight, DW Branch, TL Ortel - bmj, 2023 - bmj.com
… antiphospholipid antibodies (anticardiolipin antibodies or aβ2GPI) in 9.6% (56/582) of fetal
deaths at >20 weeks’ gestation, and therefore threefold to fivefold increased odds of stillbirth.…
deaths at >20 weeks’ gestation, and therefore threefold to fivefold increased odds of stillbirth.…
EULAR recommendations for the management of antiphospholipid syndrome in adults
MG Tektonidou, L Andreoli, M Limper… - Annals of the …, 2019 - ard.bmj.com
… High-risk antiphospholipid antibody (aPL) profile is associated with greater risk for
thrombotic and obstetric APS. Risk modification includes screening for and management of …
thrombotic and obstetric APS. Risk modification includes screening for and management of …
Management of antiphospholipid syndrome
A Ghembaza, D Saadoun - Biomedicines, 2020 - mdpi.com
… test results for anticardiolipin antibodies or anti-b2GPI) [23]. It has been shown that confirmation
of aPL positivity on two occasions at least 12 weeks apart was usually associated with …
of aPL positivity on two occasions at least 12 weeks apart was usually associated with …
Antiphospholipid syndrome: a clinical perspective
… Obstetric APS management should be tailored based on an individual patient’s antiphospholipid
antibody profile, and obstetric and thrombotic history. Pharmacological agents beyond …
antibody profile, and obstetric and thrombotic history. Pharmacological agents beyond …
… of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid …
… antiphospholipid antibodies (aPLs).1 The major goal of the management of APS is the
prevention of first or recurrent thrombotic or obstetric complications. Oral anticoagulation with …
prevention of first or recurrent thrombotic or obstetric complications. Oral anticoagulation with …
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach
… While the definitive role of statins for primary thrombosis prevention among aPL-positive
patients remains unclear, the 16th International Congress on Antiphospholipid Antibodies …
patients remains unclear, the 16th International Congress on Antiphospholipid Antibodies …
Management of antiphospholipid syndrome in adults: The European League Against Rheumatism (EULAR) recommendations
M Veselinovic, A Tomic Lucic, V Jakovljevic, A Aničić - 2019 - scidar.kg.ac.rs
… Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with
recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). …
recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). …
Aspirin prophylaxis during pregnancy: a systematic review and meta-analysis
YJ Choi, S Shin - American Journal of Preventive Medicine, 2021 - Elsevier
Context Low-dose aspirin is used for pre-eclampsia prophylaxis during pregnancy, but a
study that comprehensively investigates both maternal and perinatal outcomes from aspirin …
study that comprehensively investigates both maternal and perinatal outcomes from aspirin …
Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?
R Horgan, YH Diab, J Waller, A Abuhamad… - American Journal of …, 2023 - Elsevier
The American College of Obstetricians and Gynecologists recommends initiation of 81 mg
of aspirin daily for women at risk of preeclampsia between 12 and 28 weeks’ gestation, …
of aspirin daily for women at risk of preeclampsia between 12 and 28 weeks’ gestation, …